CHECK OUT THE END OF DOPESICK EPISODE 4 EXPLANATION ON DISNEY PLUS! SPOILERS!
Dopesick is available on Disney Plus! If you want to know the explanation for the end of Episode 4, read on! There is nothing predictable about Hulu’s limited series, Dopesick. As soon as you think the drama is going to deviate to the right, it goes to the left and vice versa. Dr. Samuel Finnix, played by Michael Keaton, is a perfect example of this. Read this to find out when the next episode will be available.
This widower started prescribing OxyContin to his patients because he truly believed it could provide relief from their chronic pain, especially in coal miners. Finnix attended a Pain Management Seminar hosted by Purdue Pharma in Arizona.
And while he was there, he met doctors and specialists whom he admired and idolized. He even gave a presentation as an expert at the seminar. On Disney Plus, we discuss the conclusion of Dopesick Episode 4!
DISNEY PLUS DOPESICK EPISODE 4 ENDING EXPLANATION
It’s no surprise that after spending the entire episode trying to quit the pill, Finnix succumbs to his temptations and obtains OxyContin from a local drug dealer. After taking a dose, Finnix sees a photo of his wife and hallucinates while dancing with her.
It is a tender moment that reminds the doctor of good times. This particular moment, on the other hand, could herald Finnix’s eventual recovery from his addiction. Finnix’s sobriety may be aided by memories of his wife.
In addition, his first-hand experience with the drug as well as his observation of its effects on his patients will make Finnix a strong witness in the case against Purdue Pharma. Much like Finnix’s addiction, most of his recovery will likely take place offscreen.
For their part, Mountcastle and Ramseyer are looking for original research claiming that less than 1% of opioid users become addicted to drugs. Jick is called to court, where he reveals his study was just an observation conducted in a hospital with a small number of patients.
Patients are less likely to develop a reliance on opioids in a carefully controlled environment, according to his findings. Jick also feels that in an open setting, the chances of these people becoming addicted are substantially higher.
Portenoy is a well-known spokesperson for Purdue Pharma. This, therefore, allows prosecutors to directly indict Purdue Pharma in the criminal misrepresentation case. While this is a significant breakthrough in the case for Mountcastle and Ramseyer, it will be difficult for them to prove Purdue’s guilt in this case, given the various loopholes the company has taken advantage of. However, the case is starting to be watertight, and Purdue’s downfall is destined.